TITLE

Outcome for Women ⩾ 43 years

PUB. DATE
September 2013
SOURCE
Fertility Weekly;9/9/2013, p7
SOURCE TYPE
Academic Journal
DOC. TYPE
Article
ABSTRACT
The article presents a study by M.B. Cetinkaya and colleagues which examines the outcomes for women ages 43 and up after in vitro fertilization and intracytoplasmic sperm injection (IVF/ICSI) cycles. It says that the authors conducted controlled ovarian stimulation through microdose gonadotropin releasing hormone (GnRH) agonist. The authors concluded that the assisted reproductive technology (ART) cycles will not benefit women 45 years and above using their own oocytes based from the outcomes.
ACCESSION #
90648845

 

Related Articles

  • Effect of a low dose of gonadotropin releasing hormone antagonist on in vitro fertilization outcomes. Kerimoğlu, Özlem; Ercan, Cihangir; Keskin, Uğur; Korkmaz, Cem; Duru, Namık; Ergün, Ali // Archives of Gynecology & Obstetrics;Sep2013, Vol. 288 Issue 3, p691 

    Purpose: This study aims to determine whether a low dose of the gonadotropin releasing hormone antagonist, cetrorelix, prevents a premature luteinizing hormone (LH) surge and affects in vitro fertilization (IVF) outcomes compared to the standard dose of 0.25 mg/day. Methods: In this study, 45...

  • Prospective comparison of short and long GnRH agonist protocols using recombinant gonadotrophins for IVF/ICSI treatments. Chi-Hong Ho; Shee-Uan Chen; Fu-Shiang Peng; Chih-Yuan Chang; Yih-Ron Lien; Yu-Shih Yang // Reproductive BioMedicine Online (Reproductive Healthcare Limited;May2008, Vol. 16 Issue 5, p632 

    This is a prospective comparative study investigating cost and effectiveness of IVF/intracytoplasmic sperm injection (ICSI) treatments after stimulation with recombinant gonadotrophins following either the short or long gonadotrophin-releasing hormone (GnRH) agonist protocol. Patients in the...

  • Registro chileno de técnicas de reproducción asistida, 2010. Schwarze Juan Enrique, M. // Revista Chilena de Obstetricia y Ginecología;Mar2013, Vol. 78 Issue 2, p82 

    Aims: To present the Chilean Registry of Assisted Reproductive Technologies performed in 2010. For the first time this registry is performed on a case-by-case basis. Results: Seven centres reported 1,238 cycles: 143 in vitro fertilization cases (IVF); 1,087 intracytoplasmatic sperm injection...

  • Effect of estrogen priming through luteal phase and stimulation phase in poor responders in in-vitro fertilization. Chang, Eun; Han, Ji; Won, Hyung; Kim, You; Yoon, Tae; Lee, Woo // Journal of Assisted Reproduction & Genetics;Mar2012, Vol. 29 Issue 3, p225 

    Purpose: To verify whether a novel protocol administering E during the luteal phase of the preceding cycle and during ovarian stimulation in GnRH antagonist cycle could enhance follicular response and hence improve outcomes in poor responders. Methods: In this retrospective analysis, a total of...

  • Tumor necrosis factor-308 polymorphism increases the embryo implantation rate in women undergoing in vitro fertilization. Vialard, F.; El Sirkasi, M.; Tronchon, V.; Boudjenah, R.; Molina-gomes, D.; Bergere, M.; Mauduit, C.; Wainer, R.; Selva, J.; Benahmed, M. // Human Reproduction;Oct2013, Vol. 28 Issue 10, p2774 

    STUDY QUESTION Do TNF-308 and -238 polymorphisms impact the embryo implantation rate after in vitro fertilization (IVF) in women without female infertility factor? SUMMARY ANSWER The presence of the TNF-308A allele is associated with high implantation and multiple pregnancy rates in women...

  • SELECTED ORAL COMMUNICATION SESSION, SESSION 33: AGONISTS AND ANTAGONISTS, Tuesday 5 July 2011 10:00 – 11:30.  // Human Reproduction;Jan2011 Supplement 1, Vol. 26 Issue suppl_1, pi46 

    No abstract available.

  • The role of GnRH antagonists in assisted reproduction. Barri, Pedro N.; Martinez, Francisca; Coroleu, Buenaventura; Tur, Rosa // Reproductive BioMedicine Online (Reproductive Healthcare Limited;Nov2002 Supplement 1, Vol. 5 Issue S1, p14 

    The different schemes of application of gonadotrophin-releasing hormone (GnRH) antagonists in ovarian stimulation protocols for assisted reproduction are reviewed. Starting from the initial schemes of single and/or multiple doses, the efficacy of GnRH antagonists in 'soft' protocols of ovarian...

  • Comparing GnRH agonist long protocol and gnrh antagonist protocol in outcome the first cycle of ART. Firouzabadi, Razieh; Ahmadi, Shahnaz; Oskouian, Homa; Davar, Robab // Archives of Gynecology & Obstetrics;Jan2010, Vol. 281 Issue 1, p81 

    This prospective study evaluated the efficacy of gonadotropin-releasing hormone (GnRH) antagonist protocol in comparison with the GnRH agonist protocol in the first cycle of assisted reproductive technique (ART). We randomized 235 patients undergoing ART for the first time. The first group was...

  • Ovarian reserve markers and assisted reproductive technique (ART) outcomes in women with advanced endometriosis. Wahd1, Safiya A.; Al Alaf, Shahla K.; Al-Shawaf, Talha; Al-Tawil, Namir G. // Reproductive Biology & Endocrinology;2014, Vol. 12 Issue 1, p1 

    Background The role of ovarian reserve markers as predictors of the controlled ovarian stimulation (COS) response in intracytoplasmic sperm injection (ICSI) cycles in women with endometriosis has been much debated. The aim of the present study is to assess the predictability of ovarian reserve...

Share

Read the Article

Courtesy of THE LIBRARY OF VIRGINIA

Sorry, but this item is not currently available from your library.

Try another library?
Sign out of this library

Other Topics